Furthermore, intracerebralinjection of fibroblasts genetically engineered to secrete IL-2 into anestablished intracerebral glioma was effective both in prolonging survival andstimulating a systemic antitumor immune response as measured in the spleencells using an IFN-γ ELISPOT assay. The gene discussed is IL2; the disease is glioma.